Amyloidosis: The rapidly changing face of diagnosis and therapy in AL amyloidosis
EHA Library. MERLINI G. 06/17/18; 219242 Topic: 3Ed Monoclonal immunoglobulin deposition diseases (e.g. amyloidosis)
Prof. GIAMPAOLO MERLINI
Prof. GIAMPAOLO MERLINI
Contributions
Learning Objectives
• improve the capability of making an early diagnosis of AL amyloidosis using biomarkers and imaging techniques,
• select appropriate upfront therapy based on risk assessment and establish an effective follow-up aiming at hematologic and organ response, and
• exploit the latest therapeutical developments, particularly immunotherapy, towards improved cardiac response and extended survival.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies